Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001801049 | SCV002046450 | uncertain significance | not provided | 2020-11-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002074149 | SCV002484493 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-09-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359260 | SCV002647298 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-12-08 | criteria provided, single submitter | clinical testing | The p.H1932R variant (also known as c.5795A>G), located in coding exon 10 of the BRCA2 gene, results from an A to G substitution at nucleotide position 5795. The histidine at codon 1932 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
University of Washington Department of Laboratory Medicine, |
RCV002359260 | SCV003849114 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |